Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alkermes plc.ALKS · Entity 2392 | EVP, R&D & CMO, Alkermes, Inc. | May 28, 2017 | May 30, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alkermes plc.
Report date May 28, 2017 · Filed May 30, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 57,056 |
Ending reported balance
After 2017-05-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-05-28 · Exercise / conversion · Acquired 3,750 · Balance 58,821 Row 2 · 2017-05-28 · Tax withholding · Disposed 1,765 · Balance 57,056 |
| Restricted Stock Unit AwardSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-05-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-05-28 · Exercise / conversion · Disposed 3,750 · Balance 0 F1: This RSU award is fully vested in accordance with its terms. |
Filing footnotes · ownership attribution and instrument terms
F1: This RSU award is fully vested in accordance with its terms.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 28, 2017 Filed May 30, 2017 17:30 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 3,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-019705 · form4.xml · derivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This RSU award is fully vested in accordance with its terms. F1 · derivative.expiration_date: This RSU award is fully vested in accordance with its terms. Read SEC document |
| May 28, 2017 Filed May 30, 2017 17:30 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 1,765 | $57.70 | $101,840.50 |
DisclosureSEC source: 0001127602-17-019705 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,056 Read SEC document |
| May 28, 2017 Filed May 30, 2017 17:30 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-019705 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2017 Filed Apr 18, 2017 17:13 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-17-014942 · form4.xml · derivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,801 Underlying: Ordinary Shares · 10,000 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| April 17, 2017 Filed Apr 18, 2017 17:13 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 10,000 | $56.60 | $565,986.00 |
DisclosureSEC source: 0001127602-17-014942 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,071 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.17 to $57.0975. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 17, 2017 Filed Apr 18, 2017 17:13 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 10,000 | $16.55 | $165,500.00 |
DisclosureSEC source: 0001127602-17-014942 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 22:17 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-17-011997 · form4.xml · derivative · entry 4 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,801 Underlying: Ordinary Shares · 10,000 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 22:17 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 6,900 | $57.00 | $393,320.70 |
DisclosureSEC source: 0001127602-17-011997 · form4.xml · nonDerivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,071 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.63 to $57.29. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 22:17 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 4,100 | $56.29 | $230,786.54 |
DisclosureSEC source: 0001127602-17-011997 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,971 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.62 to $56.55. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 22:17 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 10,000 | $16.55 | $165,500.00 |
DisclosureSEC source: 0001127602-17-011997 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 22:35 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 3,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-010466 · form4.xml · derivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Ordinary Shares · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 3/3/2015. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 3/3/2015. Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 22:35 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 1,765 | $60.97 | $107,612.05 |
DisclosureSEC source: 0001127602-17-010466 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,071 Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 22:35 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-010466 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 23:00 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 5,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009853 · form4.xml · derivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,250 Underlying: Ordinary Shares · 5,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 3/1/2017. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 3/1/2017. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 23:00 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 2,706 | $59.71 | $161,575.26 |
DisclosureSEC source: 0001127602-17-009853 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,086 Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 23:00 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 5,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009853 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2017 Filed Feb 27, 2017 22:41 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 3,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008683 · form4.xml · derivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Ordinary Shares · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/26/2016. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/26/2016. Read SEC document |
| February 26, 2017 Filed Feb 27, 2017 22:41 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 1,765 | $52.98 | $93,509.70 |
DisclosureSEC source: 0001127602-17-008683 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,042 Read SEC document |
| February 26, 2017 Filed Feb 27, 2017 22:41 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008683 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2017 Filed Feb 21, 2017 23:03 UTC | Alkermes plc. ALKS · Entity 2392 | GiftOrdinary Shares | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007489 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,057 Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 23:03 UTC | Alkermes plc. ALKS · Entity 2392 | GrantEmployee Stock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $54.57 | $0.00 |
DisclosureSEC source: 0001127602-17-007489 · form4.xml · derivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Ordinary Shares · 65,000 shares Expires 2027-02-17 F2 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 23:03 UTC | Alkermes plc. ALKS · Entity 2392 | GrantRestricted Stock Unit Award · Derivative | 15,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007489 · form4.xml · derivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 16, 2017 Filed Feb 16, 2017 22:56 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-17-006681 · form4.xml · derivative · entry 5 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,801 Underlying: Ordinary Shares · 10,000 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| February 16, 2017 Filed Feb 16, 2017 22:56 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 6,085 | $56.84 | $345,853.75 |
DisclosureSEC source: 0001127602-17-006681 · form4.xml · nonDerivative · entry 4 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,657 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.56 to $57.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 16, 2017 Filed Feb 16, 2017 22:56 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 3,915 | $56.05 | $219,417.74 |
DisclosureSEC source: 0001127602-17-006681 · form4.xml · nonDerivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,742 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.56 to $56.55. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 16, 2017 Filed Feb 16, 2017 22:56 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 10,000 | $16.55 | $165,500.00 |
DisclosureSEC source: 0001127602-17-006681 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 22:56 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 1,000 | $58.17 | $58,170.00 |
DisclosureSEC source: 0001127602-17-006681 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,657 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 17, 2017 Filed Jan 18, 2017 22:06 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-17-001900 · form4.xml · derivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,801 Underlying: Ordinary Shares · 10,000 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 17, 2017 Filed Jan 18, 2017 22:06 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 11,983 | $54.32 | $650,945.32 |
DisclosureSEC source: 0001127602-17-001900 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,657 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.06 to $54.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 17, 2017 Filed Jan 18, 2017 22:06 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 10,000 | $16.55 | $165,500.00 |
DisclosureSEC source: 0001127602-17-001900 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 06, 2017 Filed Jan 6, 2017 23:28 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,100 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · derivative · entry 10 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 2,100 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 06, 2017 Filed Jan 6, 2017 23:28 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 2,100 | $60.12 | $126,246.33 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · nonDerivative · entry 7 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,640 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 06, 2017 Filed Jan 6, 2017 23:28 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 2,100 | $18.11 | $38,020.50 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · nonDerivative · entry 6 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 23:28 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 400 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · derivative · entry 9 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,100 Underlying: Ordinary Shares · 400 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 23:28 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 400 | $60.08 | $24,031.00 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · nonDerivative · entry 5 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,640 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Cancel Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 23:28 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 400 | $18.11 | $7,242.00 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · nonDerivative · entry 4 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 23:28 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · derivative · entry 8 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Ordinary Shares · 7,500 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 23:28 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 2,500 | $60.01 | $150,022.00 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · nonDerivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,640 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.04. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 23:28 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 5,000 | $58.83 | $294,126.00 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,140 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.80 to $59.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 23:28 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 7,500 | $18.11 | $135,787.50 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,140 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 00:00 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-16-070167 · form4.xml · derivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Ordinary Shares · 5,000 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 00:00 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 5,000 | $55.99 | $279,963.00 |
DisclosureSEC source: 0001127602-16-070167 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,640 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.81 to $56.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 00:00 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 5,000 | $18.11 | $90,525.00 |
DisclosureSEC source: 0001127602-16-070167 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 23:04 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-16-069951 · form4.xml · derivative · entry 5 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Ordinary Shares · 5,000 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 23:04 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-16-069951 · form4.xml · derivative · entry 4 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,801 Underlying: Ordinary Shares · 10,000 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 23:04 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 16,983 | $55.15 | $936,631.13 |
DisclosureSEC source: 0001127602-16-069951 · form4.xml · nonDerivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,640 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.86 to $55.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 23:04 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 5,000 | $18.11 | $90,525.00 |
DisclosureSEC source: 0001127602-16-069951 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 23:04 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 10,000 | $16.55 | $165,500.00 |
DisclosureSEC source: 0001127602-16-069951 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 07, 2016 Filed Nov 8, 2016 22:06 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,517 | $0.00 Strike: $11.74 | $0.00 |
DisclosureSEC source: 0001127602-16-066413 · form4.xml · derivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,517 shares Expires 2020-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| November 07, 2016 Filed Nov 8, 2016 22:06 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 1,852 | $53.97 | $99,952.44 |
DisclosureSEC source: 0001127602-16-066413 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,623 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.